We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
CM Life Sciences Inc | NASDAQ:CMLF | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.60 | 11.70 | 11.85 | 0 | 01:00:00 |
Delaware | 001-39482 | 85-1966622 | ||||||||||||||||||
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||||||||
333 Ludlow Street, North Tower | 06902 | |||||||||||||||||||
Stamford, | Connecticut | |||||||||||||||||||
(Address of Principal Executive Offices) | (Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Class A common stock, par value $0.0001 per share | WGS | The Nasdaq Global Select Market | ||||||||||||
Warrants to purchase one share of Class A common stock, each at an exercise price of $379.50 per share | WGSWW | The Nasdaq Global Select Market |
Nominee | Votes For | Votes Withheld | ||||||
Katherine Stueland | 9,759,969 | 2,895,500 | ||||||
Jason Ryan | 9,049,659 | 3,605,810 |
Votes For | Votes Against | Abstentions | ||||||
17,113,504 | 24,127 | 3,783 |
Exhibit No | Description | ||||
104 | Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document) |
GeneDx Holdings Corp. | |||||||||||
Date: | June 20, 2023 | By: | /s/ Katherine Stueland | ||||||||
Name: | Katherine Stueland | ||||||||||
Title: | Chief Executive Officer |
1 Year CM Life Sciences Chart |
1 Month CM Life Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions